These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 28549945)
1. Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis. Salaffi F; Di Carlo M; Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Simić Pašalić K; Balčune I; Ferraz-Amaro I; Tlustochowicz M; Butrimienė I; Punceviciene E; Toroptsova N; Grazio S; Morović-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Cutolo M Joint Bone Spine; 2018 May; 85(3):317-322. PubMed ID: 28549945 [TBL] [Abstract][Full Text] [Related]
3. How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index? Fleischmann R; van der Heijde D; Koenig AS; Pedersen R; Szumski A; Marshall L; Bananis E Ann Rheum Dis; 2015 Jun; 74(6):1132-7. PubMed ID: 25143522 [TBL] [Abstract][Full Text] [Related]
4. Defining cut-off values for disease activity states and improvement scores for patient-reported outcomes: the example of the Rheumatoid Arthritis Impact of Disease (RAID). Dougados M; Brault Y; Logeart I; van der Heijde D; Gossec L; Kvien T Arthritis Res Ther; 2012 May; 14(3):R129. PubMed ID: 22647431 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Rheumatoid Arthritis Impact of Disease (RAID) Score in Assessing Rheumatoid Arthritis Activity in Teleconsultation. Avouac J; Molto A; Allanore Y J Rheumatol; 2024 Oct; 51(10):973-977. PubMed ID: 38825352 [TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes in Asia: evaluation of the properties of the Rheumatoid Arthritis Impact of Disease (RAID) score in multiethnic Asian patients with rheumatoid arthritis. Cheung PP; Lahiri M; March L; Gossec L Clin Rheumatol; 2017 May; 36(5):1149-1154. PubMed ID: 28039541 [TBL] [Abstract][Full Text] [Related]
7. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity. Holten K; Paulshus Sundlisæter N; Sexton J; Nordberg LB; Uhlig T; Kvien TK; Solomon DH; Haavardsholm EA; Lillegraven S; Aga AB; RMD Open; 2024 Jan; 10(1):. PubMed ID: 38216290 [TBL] [Abstract][Full Text] [Related]
8. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care. Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S; Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335 [TBL] [Abstract][Full Text] [Related]
9. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis. Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459 [TBL] [Abstract][Full Text] [Related]
10. Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis. Ter Wee MM; van Tuyl LH; Blomjous BS; Lems WF; Boers M; Terwee CB Arthritis Res Ther; 2016 Jan; 18():22. PubMed ID: 26794406 [TBL] [Abstract][Full Text] [Related]
11. Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis. González-Álvaro I; Castrejón I; Ortiz AM; Toledano E; Castañeda S; García-Vadillo A; Carmona L; PLoS One; 2016; 11(9):e0161727. PubMed ID: 27603313 [TBL] [Abstract][Full Text] [Related]
12. European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). Vojinovic J; Tincani A; Sulli A; Soldano S; Andreoli L; Dall'Ara F; Ionescu R; Pasalic KS; Balcune I; Ferraz-Amaro I; Tlustochowicz M; Butrimiene I; Punceviciene E; Toroptsova N; Grazio S; Morovic-Vergles J; Masaryk P; Otsa K; Bernardes M; Boyadzhieva V; Salaffi F; Cutolo M Autoimmun Rev; 2017 May; 16(5):548-554. PubMed ID: 28279841 [TBL] [Abstract][Full Text] [Related]
13. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire. Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593 [TBL] [Abstract][Full Text] [Related]
14. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients. Curtis JR; Yang S; Chen L; Pope JE; Keystone EC; Haraoui B; Boire G; Thorne JC; Tin D; Hitchon CA; Bingham CO; Bykerk VP Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1345-53. PubMed ID: 25988705 [TBL] [Abstract][Full Text] [Related]
15. Rheumatoid Arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Salaffi F; Di Carlo M; Farah S; Marotto D; Atzeni F; Sarzi-Puttini P Acta Biomed; 2021 Sep; 92(4):e2021238. PubMed ID: 34487094 [TBL] [Abstract][Full Text] [Related]
16. Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity. Tymms K; Zochling J; Scott J; Bird P; Burnet S; de Jager J; Griffiths H; Nicholls D; Roberts L; Arnold M; Littlejohn G Arthritis Care Res (Hoboken); 2014 Feb; 66(2):190-6. PubMed ID: 23983001 [TBL] [Abstract][Full Text] [Related]
17. The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis. Salaffi F; Di Carlo M; Iannone F; Fedele AL; Epis OM; Pellerito R; Foti R; Passiu G; Punzi L; Furini F; Sarzi-Puttini P; Carletto A; Gremese E; Lapadula G; Ferraccioli G Semin Arthritis Rheum; 2018 Apr; 47(5):619-629. PubMed ID: 29102157 [TBL] [Abstract][Full Text] [Related]
18. Patient- and clinician-reported outcomes for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis. Ledingham JM; Snowden N; Rivett A; Galloway J; Ide Z; Firth J; MacPhie E; Kandala N; Dennison EM; Rowe I Rheumatology (Oxford); 2017 Feb; 56(2):231-238. PubMed ID: 27694336 [TBL] [Abstract][Full Text] [Related]
19. Defining criteria for disease activity states in nonsystemic juvenile idiopathic arthritis based on a three-variable juvenile arthritis disease activity score. Consolaro A; Negro G; Chiara Gallo M; Bracciolini G; Ferrari C; Schiappapietra B; Pistorio A; Bovis F; Ruperto N; Martini A; Ravelli A Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1703-9. PubMed ID: 24980508 [TBL] [Abstract][Full Text] [Related]
20. Defining criteria for disease activity states in juvenile dermatomyositis based on the Juvenile Dermatomyositis Activity Index. Rosina S; Consolaro A; Pistorio A; Rebollo-Giménez A; Bracaglia C; Dolezalova P; Guilaisne Bernard-Medina A; Herlin T; Trachana M; Vargová V; Wouters C; Carenini L; Ruperto N; Ravelli A; RMD Open; 2024 Feb; 10(1):. PubMed ID: 38307698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]